Home › Funds › Boxer Capital Management, LLC › ANTX
Boxer Capital Management, LLC position in ANTX
AN2 THERAPEUTICS INC · Health Care
Boxer Capital Management, LLC reported holding 749,035 shares of ANTX (AN2 THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$3.6M, representing 0.27% of its reported portfolio and ranking #46 among its reported holdings. Boxer Capital Management, LLC has disclosed ANTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Boxer Capital Management, LLC's ANTX position evolved
Boxer Capital Management, LLC first disclosed a stake in ANTX in Q1 2026 at 749,035 shares (US$2.6M). The position peaked in Q2 2026 at 749,035 shares, worth US$3.6M. Across 2 filings, Boxer Capital Management, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 749,035 shares valued at US$3.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 749.03K | $2.56M | New |
| Q2 2026 | 749.03K | $3.63M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANTX and 13F data
ANTX (AN2 THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in ANTX — the largest reported positions include Vivo Capital, LLC (US$15.3M), Commodore Capital LP (US$14.2M), Spruce Street Capital LP (US$8.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANTX
- Vivo Capital, LLC 3.15M sh · $15.26M · Q2 2026
- Commodore Capital LP 2.93M sh · $14.20M · Q2 2026
- Spruce Street Capital LP 1.66M sh · $8.04M · Q2 2026
- Almitas Capital LLC 1.47M sh · $7.11M · Q2 2026
- Stonepine Capital Management, LLC 551.69K sh · $2.67M · Q2 2026
- Sio Capital Management, LLC 529.93K sh · $2.56M · Q2 2026
- Ally Bridge Group (NY) LLC 526.32K sh · $2.55M · Q2 2026
- Prosight Management, LP 474.64K sh · $2.30M · Q2 2026
- Aldebaran Capital, LLC 367.44K sh · $1.78M · Q2 2026
- Velan Capital Investment Management LP 40.00K sh · $193.60K · Q2 2026
More on Boxer Capital Management, LLC
FAQ
How long has Boxer Capital Management, LLC held ANTX?
Boxer Capital Management, LLC has disclosed ANTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Boxer Capital Management, LLC's current position in ANTX?
As of Q2 2026, Boxer Capital Management, LLC holds 749.03K shares of ANTX (AN2 THERAPEUTICS INC), valued at $3.63M, representing 0.27% of its reported portfolio and ranking #46.
Has Boxer Capital Management, LLC been buying or selling ANTX?
In the latest 13F filing (Q2 2026), Boxer Capital Management, LLC held unchanged its position in ANTX. The position peaked in Q2 2026 at 749.03K shares.
Which other funds hold ANTX?
Other major institutional holders of ANTX include Vivo Capital, LLC, Commodore Capital LP, Spruce Street Capital LP, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.